For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study ...

November is National Diabetes Awareness Month and a recent survey by Episcopal Health Foundation shows that nearly half of ...

Your doctor broke news you didn’t want to hear: you have prediabetes, a condition where blood sugar is elevated, but not high ...

The continued use of a new obesity treatment can lead to weight loss of up to 23 per cent and a 94 per cent reduction in ...

For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study ...

Epitomee Medical Ltd. (TASE: EPIT) announces that significant results from its RESET study on a novel oral hydrogel capsule ...

November marks American Diabetes Month, with healthcare providers, public health agencies, educators and community ...

Findings from a 3-year analysis demonstrated that among patients treated with tirzepatide, 98.8% remained diabetes free.

Cohn and Chenoy recommended several ways to reverse prediabetes. "If, despite these measures, blood sugar levels remain ...

Diabetes mellitus is a common, chronic metabolic disease that affects a variety of organs including the skin, the largest organ in the body. Between 30 and 70 percent of people ...

American Diversified Holdings Corporation (ADHC) Retains Dr. Stephen C. Weber, MD, FACS As Head of Medical Advisory Board ...

Managing pre-diabetes requires actionable steps to improve your health and lower your risk of developing diabetes. Reducing ...